Log In
Print
BCIQ
Print
Print this Print this
 

Rotarix (formerly RIX4414)

  Manage Alerts
Collapse Summary General Information
Company Celldex Therapeutics Inc.
DescriptionOral attenuated rotavirus vaccine
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationRotavirus
Indication DetailsPrevent gastroenteritis due to rotavirus infection; Prevent rotavirus infection; Vaccinate against rotavirus; Vaccinate against severe rotavirus gastroenteritis
Regulatory Designation
Partner Daiichi Sankyo Co. Ltd.; GlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1.2M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today